Site Mobile Navigation

COMPANY NEWS; A President For Amgen

This is a digitized version of an article from The Times’s print archive, before the start of online publication in 1996.
To preserve these articles as they originally appeared, The Times does not alter, edit or update them.

Occasionally the digitization process introduces transcription errors or other problems.
Please send reports of such problems to archive_feedback@nytimes.com.

October 17, 1992, Page 001043 The New York Times Archives

Amgen Inc., a biotech pharmaceuticals company, said today that it had named an executive at MCI as president, chief operating officer and a director, effective Nov. 10.

The executive, Kevin W. Sharer, 44 years old, is now an executive vice president of the MCI Communications Corporation, as well as president of that company's business markets division. Before joining MCI in 1985 he worked for General Electric.

Brandon Fradd, an analyst with Montgomery Securities, said there were interesting parallels between MCI, a growing company up against a far larger competitor in A.T.&T., and Amgen that made the choice of Mr. Sharer, who has no pharmaceuticals experience, less surprising. "This seems a good choice," he said.

Amgen has been without a president since the departure in February 1991 of Harry Hixson, who had been president since 1985. "Responsibilities were split among the existing officers," said a company spokeswoman, Kimberly Dorsey.

A version of this article appears in print on October 17, 1992, on Page 1001043 of the National edition with the headline: COMPANY NEWS; A President For Amgen. Order Reprints|Today's Paper|Subscribe